Baicalin and TLR7 agonist imiquimod treatment could relieve lupus mice by inhibiting Tfh cell differentiation and IL-21 production, and promoting Tfr cell differentiation (122, 123). The gene discussed is TFRC; the disease is systemic lupus erythematosus.